202 related articles for article (PubMed ID: 24751283)
1. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
[TBL] [Abstract][Full Text] [Related]
5. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
[TBL] [Abstract][Full Text] [Related]
6. Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment.
Denimal D; Monier S; Brindisi MC; Petit JM; Bouillet B; Nguyen A; Demizieux L; Simoneau I; Pais de Barros JP; Vergès B; Duvillard L
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):804-811. PubMed ID: 28360087
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1.
Liu D; Ji L; Tong X; Pan B; Han JY; Huang Y; Chen YE; Pennathur S; Zhang Y; Zheng L
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C739-48. PubMed ID: 21734188
[TBL] [Abstract][Full Text] [Related]
9. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
10. HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro.
Fan Y; Chen J; Liu D; Li W; Wang H; Huang Y; Gao C
Int J Biochem Cell Biol; 2020 Sep; 126():105819. PubMed ID: 32750426
[TBL] [Abstract][Full Text] [Related]
11. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.
Brulhart-Meynet MC; Thomas A; Sidibé J; Visentin F; Dusaulcy R; Schwitzgebel V; Pataky Z; Philippe J; Vuilleumier N; James RW; Gosmain Y; Frias MA
Physiol Rep; 2021 Mar; 9(6):e14786. PubMed ID: 33769715
[TBL] [Abstract][Full Text] [Related]
15. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
16. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.
Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389
[TBL] [Abstract][Full Text] [Related]
17. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
18. Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate.
Perségol L; Darabi M; Dauteuille C; Lhomme M; Chantepie S; Rye KA; Therond P; Chapman MJ; Salvayre R; Nègre-Salvayre A; Lesnik P; Monier S; Kontush A
J Lipid Res; 2018 Jan; 59(1):25-34. PubMed ID: 29150495
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells.
Kimura T; Sato K; Kuwabara A; Tomura H; Ishiwara M; Kobayashi I; Ui M; Okajima F
J Biol Chem; 2001 Aug; 276(34):31780-5. PubMed ID: 11427538
[TBL] [Abstract][Full Text] [Related]
20. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
